Interestingly, serum TNF-α, which associated with disease progression (Figure 2A), was elevated in patients with both grade ≥ 3 CRS and NE (Supplemental Figure 13C), making it a promising target to improve the therapeutic index of CAR T cells. Here, TNF is linked to congenital rubella syndrome.